Skip to main content
Log in

Spectrofluorimetric Determination of Paroxetine HCl in Pharmaceuticals via Derivatization with 4-chloro-7- nitrobenzo-2-oxa-1,3-diazole (NBD-Cl)

  • Original Paper
  • Published:
Journal of Fluorescence Aims and scope Submit manuscript

Abstract

A sensitive and simple spectrofluorimetric method has been developed and validated for the determination of the antidepressant paroxetine HCl (PXT) in its dosage forms. The method was based on coupling reaction of PXT with 4-chloro-7-nitrobenzo-2- oxa-1,3-diazole (NBD-Cl) in an alkaline medium (pH 8) to form a highly fluorescent derivative that was measured at 530 nm after excitation at 460 nm. The factors affecting the formation and stability of the reaction product were carefully studied and optimized. The fluorescence–concentration plot is rectilinear over the range 0.2-6 μg/mL with LOD of 0.08 μg/mL and LOQ of 0.24 μg/mL respectively. The method was applied to the analysis of commercial tablets and the results were in good agreement with those obtained using the reference method. The mean percentage recoveries for paxetin and xandol tablets were 101.27 ± 1.79 and 101.33 ± 1.19 respectively. A proposal of the reaction pathway was postulated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Scheme 1

Similar content being viewed by others

References

  1. The British Pharmacopoeia. The stationary office: London, (2007), Electronic version

  2. Sweetman SC (ed) (2009) Martindale: the complete drug reference. Pharmaceutical, London, Electronic version

    Google Scholar 

  3. Zainaghi IA, Lanchote VL, Queiroz RHC (2003) Determination of paroxetine in geriatric depression by high performance liquid chromatography. Pharmacol Res 48:217–221

    Article  CAS  PubMed  Google Scholar 

  4. Zhu Z, Neirinck L (2002) High-performance liquid chromatography-mass spectrometry method for the determination of paroxetine in human plasma. J Chromatogr B 780:295–300

    Article  CAS  Google Scholar 

  5. Massaroti P, Cassiano NM, Durate LF (2005) Validation of a selective method for determination of paroxetine in human plasma by LC-MS/MS. J Pharm Pharm Sci 8:340–347

    CAS  PubMed  Google Scholar 

  6. Jheee OH, Seo HK, Lee MH (2007) Determination of paroxetine in plasma by liquid chromatography coupled to tandem mass spectrometry for pharmacokinetic and bioequivalence studie. Arzeneimittel-Forschung 57:455–461

    Google Scholar 

  7. British Pharmacopoeia (2003) The Stationary Office, London, UK

  8. Nouws HPA, Delerue-Matos C, Barros AA, Rodrigues JA (2006) Electroanalytical determination of paroxetine in pharmaceuticals, J Pharm Biomed Anal 42:341–346

    Article  CAS  PubMed  Google Scholar 

  9. Erk N, Biryol J (2003) Voltammetric and HPLC techniques for the determination of paroxetine hydrochloride. Pharmazie 58:699–704

    CAS  PubMed  Google Scholar 

  10. Eap CB, Bouchoux G, Amey M, Cochard N, Savary L, Baumann P (1998) Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry. J Chromatogr Sci 36:365–371

    CAS  PubMed  Google Scholar 

  11. Hans JL, Werner W, Günter F (2002) Improved sample preparation for the quantitative analysis of paroxetine in human plasma by stable isotope dilution negative ion chemical ionization gas chromatography-mass spectrometry. J Chromatogr B 779:353–357

    Article  Google Scholar 

  12. Chien L, Emily SG, Sidney HK, Alan N, Ronald TC, Glen BB (2000) Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection. J Chromatogr B 749:275–279

    Article  Google Scholar 

  13. Labat L, Deveaux M, Dallet P, Dubost JP (2002) Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography. J Chromatogr B 773:17–23

    Article  CAS  Google Scholar 

  14. Onal A, Kepekçi SE, Oztunç A (2005) Spectrophotometric methods for the determination of the antidepressant drug paroxetine hydrochloride in tablets. J AOAC Int 88:490–495

    PubMed  Google Scholar 

  15. Darwish IA, Refaat IH (2006) Spectrophotometric analysis of selective serotonin reuptake inhibitors based on formation of charge-transfer complexes with tetracyanoquinodimethane and chloranilic acid. J AOAC Int 89:326–333

    CAS  PubMed  Google Scholar 

  16. Darwish IA (2005) Development and validation of spectrophotometric methods of fluoxetine, sertraline and paroxetine in pharmaceutical dosage forms. J AOAC Int 88:38–45

    CAS  PubMed  Google Scholar 

  17. Darwish IA, Abdine H, Amer S, Al-Rayes L (2009) Simple spectrophotometric method for determination of paroxetine in tablets using 1,2-Naphthoquinone-4-sulphonate as a chromogenic reagent. International Journal of Analytical Chemistry, vol. 2009: ID 237601

  18. Taha EA, Salama NN, Fattah L (2006) Spectrofluorimetric and spectrophotometric stability-indicating methods for determination of some oxicams using 7-chloro-4-nitrobenz-2-oxa-1, 3-diazole(NBD-Cl). Chem Pharm Bull (Tokyo) 54:653–658

    Article  CAS  Google Scholar 

  19. El-Enany N, El-Sherbiny D, Belal F (2007) Spectrophotometric, spectrofluorometric and HPLC determination of desloratadine in dosage forms and human plasma. Chem Pharm Bull (Tokyo) 55:1662–1670

    Article  CAS  Google Scholar 

  20. Saleh HM, El-Henawee MM, Ragab GH, El-Hay SS (2007) Utility of NBD-Cl for the spectrophotometric determination of some skeletal muscle relaxant and antihistaminic drugs. Spectrochim Acta 67:1284–1289

    Article  Google Scholar 

  21. Olojo RO, Xia RH, Abramson JJ (2005) Spectrophotometric and fluorometric assay of superoxide ion using 4-chloro-7-nitrobenzo-2-oxa-1, 3-diazole. Anal Biochem 339:338–344

    Article  CAS  PubMed  Google Scholar 

  22. Miyano H, Toyo’oka T, Miyano H (1985) Anal Chim Acta 170:81

    Article  CAS  Google Scholar 

  23. Guidance for Industry; Q2B of Analytical Procedures: Methodology; International Conference on Hormonization (ICH), November (1996). http://www.fda.gov/eder/guidance/1320fnl.pdf (accessed September 1, 2004)

  24. Miller JN, Miller JC (2005) Statistics and chemometrics for analytical chemistry, 5th edn. Prentice Hall, England, 256

    Google Scholar 

  25. Rose (2006) J Advanced Physico-Chemical Experiments. Pitman, London, 1964

  26. El-Enany N, Belal F, Rizk M (2006) Kinetic Spectrophotometric Determination of Isoxsuprine in Dosage Forms Through Derivatization with 4-chloro-7- nitrobenzo-2-oxa-1, 3- diazole (NBD-Cl). Sci Pharm 74:99–119

    Article  CAS  Google Scholar 

  27. Crampton MR, Delaney J, Rabbitt LC (1999) Unusual reaction of 4-nitrobenzofurazan with amines. J Chem Soc Perkin Trans 2:2473

    Google Scholar 

  28. Moutires G, Pinson J, Terrier F, Goumont R (2001) Chem Eur J 7:1712

    Article  Google Scholar 

  29. Makosza M, Winiarski J (1987) Acc Chem Res 20:282–289

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nahed El-Enany.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walsh, M., Belal, F., El-Enany, N. et al. Spectrofluorimetric Determination of Paroxetine HCl in Pharmaceuticals via Derivatization with 4-chloro-7- nitrobenzo-2-oxa-1,3-diazole (NBD-Cl). J Fluoresc 21, 105–112 (2011). https://doi.org/10.1007/s10895-010-0693-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10895-010-0693-2

Keywords

Navigation